Sonova Invests €5 Million in Sensorion as the Companies Plan a Collaboration in Hearing Loss
Share: Sonova invests at €1.70 per share, to hold circa 3.7% stake in Sensorion Companies signed a letter of intent relating to a collaboration to develop new solutions for hearing loss Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces that Sonova Holding AG (headquartered in Switzerland), a leading provider of hearing solutions, will acquire a 3.7% ownership stake in Sensorion by way of ...